The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Cardioquip sales in the US from 2017 to 2023, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
CardioFocus Inc (CardioFocus) is a medical device company that manufactures and distributes endoscopic ablation systems for the treatment of cardiac disorders. The company’s products include heartlight x3 endoscopic cardiac ablation system, endoscopic ablation system, compatible mapping systems and ablation catheters, among others. It markets products under the brands HeartLight, Centauri, EnSite, Carto, TactiCath, Rhythmia HDx, IntellaNav Stablepoint. HeartLight X3 System provides electrophysiologist with a laser balloon catheter designed to perform PVI procedures. CardioFocus is headquartered in Marlborough, Massachusetts, the US.
The key metrics of Cardioquip related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2023 are shown below:
As Cardioquip is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Cardioquip.
For a detailed understanding of the performance of Cardioquip, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.